Self-monitoring of blood glucose in type 2 diabetes
ABSTRACT
Haidar, E.A.C. et al (2008) Self-monitoring of blood glucose in type 2 diabetes This is an extended version of the article published in Nursing Times; 104: 3, 32-33.
BACKGROUND: The value of self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes treated with oral hypoglycaemic agents is controversial.
AIM: To assess the effect of SMBG on glycaemic control in type 2 diabetes.
METHOD: An observational prospective study with historical controls was carried out in a socially deprived general practice. Participants were 100 patients of South Asian origin with type 2 diabetes. Sixty-seven patients completed: 32 females, 35 males. Patients were educated and performed SMBG.
MAIN OUTCOME MEASURES: HbA1c and fasting blood glucose (FBG) were checked at three, six and nine months and compared with baseline data.
RESULTS: There was a significant difference between pre-SMBG HbA1c (mean 9.8%, SD +/-2.4) and post-SMBG (mean 8.5%, SD+/-2.1). One-way ANOVA confirmed a significant difference between pre and post results of HbA1c and FBG.
CONCLUSION: SMBG improved glycaemic control in patients with type 2 diabetes.
ABSTRACT
Haidar, E.A.C. et al (2008) Self-monitoring of blood glucose in type 2 diabetes This is an extended version of the article published in Nursing Times; 104: 3, 32-33.
BACKGROUND: The value of self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes treated with oral hypoglycaemic agents is controversial.
AIM: To assess the effect of SMBG on glycaemic control in type 2 diabetes.
METHOD: An observational prospective study with historical controls was carried out in a socially deprived general practice. Participants were 100 patients of South Asian origin with type 2 diabetes. Sixty-seven patients completed: 32 females, 35 males. Patients were educated and performed SMBG.
MAIN OUTCOME MEASURES: HbA1c and fasting blood glucose (FBG) were checked at three, six and nine months and compared with baseline data.
RESULTS: There was a significant difference between pre-SMBG HbA1c (mean 9.8%, SD +/-2.4) and post-SMBG (mean 8.5%, SD+/-2.1). One-way ANOVA confirmed a significant difference between pre and post results of HbA1c and FBG.
CONCLUSION: SMBG improved glycaemic control in patients with type 2 diabetes.
The page you have tried to access is subscriber-only content.
If you are already a subscriber to Nursing Times magazine and have activated your subscription, but have not signed in, please click here
If you are already a subscriber to Nursing Times magazine, please click here to activate your subscription and ensure you have access to the whole of the website.
If you would like to subscribe to Nursing Times magazine and get access to the whole of the website, please click here
